Health Catalyst, Inc. (NASDAQ:HCAT) General Counsel Benjamin Landry Sells 19,268 Shares

Health Catalyst, Inc. (NASDAQ:HCAT) General Counsel Benjamin Landry sold 19,268 shares of Health Catalyst stock in a transaction dated Friday, December 6th. The stock was sold at an average price of $8.32, for a total value of $160,309.76. Following the completion of the transaction, the general counsel now directly owns 72,250 shares of the company’s stock, valued at approximately $601,120. This represents a 21.05 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link.

Health Catalyst Stock Performance

Health Catalyst stock traded up $0.03 during mid-day trading on Tuesday, reaching $8.37. 393,567 shares of the stock traded hands, compared to its average volume of 564,733. The stock has a market capitalization of $509.30 million, a PE ratio of -6.20 and a beta of 1.31. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.41 and a quick ratio of 1.41. The business’s 50-day moving average is $8.13 and its 200-day moving average is $7.39. Health Catalyst, Inc. has a 12-month low of $5.42 and a 12-month high of $11.41.

Health Catalyst (NASDAQ:HCAT) last issued its quarterly earnings data on Wednesday, November 6th. The company reported $0.07 earnings per share for the quarter, missing the consensus estimate of $0.10 by ($0.03). The business had revenue of $76.40 million during the quarter, compared to the consensus estimate of $76.27 million. Health Catalyst had a negative return on equity of 7.51% and a negative net margin of 26.20%. Health Catalyst’s revenue for the quarter was up 3.5% on a year-over-year basis. During the same quarter last year, the company earned ($0.22) EPS. As a group, sell-side analysts predict that Health Catalyst, Inc. will post -0.33 EPS for the current fiscal year.

Hedge Funds Weigh In On Health Catalyst

Institutional investors have recently bought and sold shares of the stock. Quest Partners LLC bought a new stake in Health Catalyst during the third quarter valued at about $34,000. Nisa Investment Advisors LLC lifted its position in shares of Health Catalyst by 461.0% during the 2nd quarter. Nisa Investment Advisors LLC now owns 6,367 shares of the company’s stock valued at $41,000 after buying an additional 5,232 shares in the last quarter. Quarry LP grew its stake in shares of Health Catalyst by 59.4% during the 2nd quarter. Quarry LP now owns 7,002 shares of the company’s stock valued at $45,000 after acquiring an additional 2,610 shares during the period. nVerses Capital LLC purchased a new stake in Health Catalyst in the 3rd quarter worth approximately $59,000. Finally, Perfromance Wealth Partners LLC bought a new stake in Health Catalyst during the 2nd quarter worth approximately $64,000. 85.00% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

HCAT has been the subject of several recent analyst reports. Citigroup lifted their target price on shares of Health Catalyst from $9.00 to $10.50 and gave the stock a “buy” rating in a report on Wednesday, November 13th. Evercore ISI boosted their price objective on shares of Health Catalyst from $8.00 to $10.00 and gave the stock an “outperform” rating in a report on Tuesday, October 8th. Royal Bank of Canada upped their price objective on Health Catalyst from $8.00 to $9.00 and gave the company a “sector perform” rating in a research report on Thursday, November 7th. Stephens lifted their target price on Health Catalyst from $7.00 to $9.00 and gave the stock an “equal weight” rating in a report on Thursday, November 14th. Finally, Cantor Fitzgerald restated an “overweight” rating and issued a $16.00 price target on shares of Health Catalyst in a research note on Friday, October 4th. Three analysts have rated the stock with a hold rating and nine have assigned a buy rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $11.79.

About Health Catalyst

Health Catalyst, Inc provides data and analytics technology and services to healthcare organizations in the United States. It operates in two segments, Technology and Professional Services. The company provides data operating system data platform which provides clients single comprehensive environment to integrate and organize data from their disparate software systems; and analytics applications, a software analytics applications build for data platform to analyze clients face across clinical and quality, population health, and financial and operational use cases.